Type
. [Spontaneous premunition against tuberculosis has not, in New Caledonia and Guiana, given protection against leprosy]. Journal des praticiens; revue generale de clinique et de therapeutique. 1950;64(3):33-4.
Type
. [Practical superiority of diamino-diphenyl-sulfone (1358 F) over complex disubstituted sulfones in the treatment of leprosy]. Medecine tropicale : revue du Corps de sante colonial. 1950;10(1):61-72.
Type
. [Infections diseases of the skin, with exception of dermatomycosis, tuberculosis and leprosy]. Dermatologica. 1950;101(1):56-63.
Type
. Endovascular repair of a thoracic aorta mycotic pseudoaneurysm in a patient with history of bacteroides fragilis sepsis and leprosy. Journal of vascular and interventional radiology : JVIR. 2005;16(2 Pt 1):298-300.
Type
. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. Journal of medical microbiology. 2005;54(Pt 3):235-42.
Type
. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy. Indian journal of public health. 2004;48(2):70-7.
Type
. Monitoring the size of the leprosy problem: which epidemiological indicators should we use?. Indian journal of public health. 2004;48(1):5-16.
Type
. Simultaneous confidence intervals for ratios with applications to the comparison of several treatments with a control. Methods of information in medicine. 2004;43(5):465-9.
Type
. [Converging plaques on the trunk]. Annales de dermatologie et de venereologie. 2004;131(12):1105-7.
Type
. Polymorphism in the rpoT gene in Mycobacterium leprae isolates obtained from Latin American countries and its possible correlation with the spread of leprosy. FEMS microbiology letters [Internet]. 2005;243(2):311-5. Available from: http://onlinelibrary.wiley.com/doi/10.1016/j.femsle.2004.12.031/pdf